Advertisement

Topics

"Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma" Drugs and Medication Database: Page 2

06:29 EDT 21st March 2019 | BioPortfolio

Here are the most relevant "Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma" Drugs and Medications that we have found in our database.

More Information about "Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma" on BioPortfolio

We have published hundreds of Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma news stories on BioPortfolio along with dozens of Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma Clinical Trials and PubMed Articles about Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma Companies in our database. You can also find out about relevant Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma Drugs and Medications on this site too.

Showing "Monoclonal Antibody Therapy Vaccine Therapy Treating Patients With" Drugs and Medications 26–50 of 93

Possibly Relevant

Prostascint kit for the preparation of indium in 111 capromab pendetide [jazz pharmaceuticals, inc.]

ProstaScintKit (capromab pendetide) Kit for the Preparation of Indium In 111 Capromab Pendetide For Intravenous Use Only

Siliq [valeant pharmaceuticals north america llc]

These highlights do not include all the information needed to use SILIQ safely and effectively. See full prescribing information for SILIQ. SILIQ™ (brodalumab) injection, for subcutaneous useInitial U.S. Approval: 2017

Siklos [medunik]

These highlights do not include all the information needed to use SIKLOS safely and effectively. See full prescribing information for SIKLOS. SIKLOS (hydroxyurea) tablets, for oral use Initial U.S. Approval: 1967

Tysabri [biogen inc.]

These highlights do not include all the information needed to use TYSABRI safely and effectively. See full prescribing information for TYSABRI.TYSABRI (natalizumab) injection, for intravenous useInitial U.S. Approval: 2004

Lartruvo [eli lilly and company]

These highlights do not include all the information needed to use LARTRUVO safely and effectively. See full prescribing information for LARTRUVO.LARTRUVO (olaratumab) injection, for intravenous useInitial U.S. Approval: 2016

Kevzara [sanofi-aventis u.s. llc]

These highlights do not include all the information needed to use KEVZARA safely and effectively. See full prescribing information for KEVZARA. KEVZARA (sarilumab) injection, for subcutaneous use Initial U.S. Approval: 2017

Cnj-016 [emergent biosolutions canada inc.]

These highlights do not include all the information needed to use CNJ-016 (vaccinia immune globulin intravenous, human), VIGIV safely and effectively. See full prescribing information for VIGIV. VIGIV (vaccinia immune globulin, human), 5% sterile solution

Tremfya [janssen biotech, inc.]

These highlights do not include all the information needed to use TREMFYA safely and effectively. See full prescribing information for TREMFYA. TREMFYA (guselkumab) injection, for subcutaneous use Initial U.S. Approval: 2017

Recombinate [baxter healthcare corporation]

RECOMBINATE [Antihemophilic Factor (Recombinant)]

Recombinate [baxter healthcare corporation]

RECOMBINATE [Antihemophilic Factor (Recombinant)]

Recombinate [baxter healthcare corporation]

RECOMBINATE [Antihemophilic Factor (Recombinant)]

Arzerra [novartis pharmaceuticals corporation]

These highlights do not include all the information needed to use ARZERRA safely and effectively. See full prescribing information for ARZERRA. ARZERRA (ofatumumab) injection, for intravenous useInitial U.S. Approval: 2009

Kineret [swedish orphan biovitrum ab (publ)]

These highlights do not include all the information needed to use KINERET safely and effectively. See full prescribing information for KINERET. KINERET® (anakinra) injection, for subcutaneous useInitial U.S. Approval: 2001

Simulect [novartis pharmaceuticals corporation]

Simulect (basiliximab) For Injection Rx only Prescribing Information

Cyclosporine [mayne pharma inc.]

Cyclosporine Capsules, USP [MODIFIED] (Soft Gelatin) Cyclosporine ORAL SOLUTION, USP [MODIFIED]

Imraldi [samsung bioepis co., ltd.]

These highlights do not include all the information needed to use IMRALDI safely and effectively. See full prescribing information for IMRALDI.IMRALDI (adalimumab-xxxx) injection, for subcutaneous useInitial U.S. Approval: YYYY IMRALDI (adalimumab-xxxx) i

Ilaris [novartis pharmaceuticals corporation]

These highlights do not include all the information needed to use ILARIS safely and effectively. See full prescribing information for ILARIS. ILARIS® (canakinumab) for injection, for subcutaneous use ILARIS® (canakinumab) injection, for subcutaneous use

Gengraf [abbvie inc.]

GENGRAF Capsules (cyclosporine capsules, USP [MODIFIED])

Gamifant [novimmune sa]

These highlights do not include all the information needed to use GAMIFANT safely and effectively. See full prescribing information for GAMIFANT. GAMIFANT (emapalumab-lzsg) injection, for intravenous useInitial U.S. Approval: 2018

Reopro [janssen biotech, inc.]

ReoPro Abciximab

Reopro [eli lilly and company]

ReoPro Abciximab

Gengraf [abbvie inc.]

GENGRAF ORAL SOLUTION(cyclosporine oral solution, USP [MODIFIED])

Portrazza [eli lilly and company]

These highlights do not include all the information needed to use PORTRAZZA safely and effectively. See full prescribing information for PORTRAZZA. PORTRAZZA (necitumumab) injection, for intravenous useInitial U.S. Approval: 2015

Winrho [aptevo biotherapeutics llc]

These highlights do not include all the information needed to use WinRho SDF safely and effectively. See full prescribing information for WinRho SDF. WinRho SDF [Rho(D) Immune Globulin Intravenous (Human)] Solution For Intravenous or Intramuscular Injecti

Cinqair [teva respiratory, llc]

These highlights do not include all the information needed to use CINQAIR safely and effectively. See full prescribing information for CINQAIR.CINQAIR (reslizumab) injection, for intravenous useInitial U.S. Approval: 2016



Advertisement
Quick Search
Advertisement
Advertisement